ArticleAsian Pacific journal of cancer prevention : APJCP2025
MUC4 and Caspase-3 Immunoexpression in Meningioma: A Histopathological Study Linking Mucin & Apoptotic Pathways.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe most frequent intracranial primary tumors of the central nervous system and the second most frequent tumors of the brain are meningiomas. Although most of them are benign, a subset of them is biologically aggressive, exhibiting aggressive growth behavior and brain invasion. MATERIALS AND
methodsFifty-nine cases of various grades & subtypes of meningiomas were included in this retrospective study. Samples were immunohistochemically analyzed for MUC4 & Caspase-3 antibodies and correlated with clinico-pathologic variables.
resultsMUC4 was expressed in 36 (61%) cases of meningioma. Statistically, MUC4 expression, the percentage of positivity of tumor cells, and the intensity were significantly positively correlated with the WHO grade of meningioma cases (p-value = 0.03, 0.006, and 0.002, respectively) and the meningioma histologic subtype (p-value = 0.002, 0.002, and 0.000, respectively). Caspase-3 was expressed in 48 (81.4%) cases of meningioma. Caspase-3 expression was statistically significantly inversely correlated with the WHO grade of the analyzed tumors (p-value= 0.005) and the meningioma histologic subtype (p-value= 0.014). There is an inverse statistically significant correlation between the intensity of MUC4 & Caspase-3 expression (p-value= 0.002).
conclusionOur results suggest that MUC4 is associated with higher grades of meningiomas and may have a negative impact on prognosis and recurrence rates, potentially making it a target for an agent with mucolytic effects that can help overcome chemoresistance in aggressive meningiomas. On the other hand, the expression of Caspase-3 correlates with the grade of differentiation and certain histotypes and may be considered as an ideal target for meningioma therapeutic regimens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.